You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 9,724,353


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,724,353 protect, and when does it expire?

Patent 9,724,353 protects ZERBAXA and is included in one NDA.

This patent has thirteen patent family members in eight countries.

Summary for Patent: 9,724,353
Title:Methods for treating intrapulmonary infections
Abstract: This disclosure relates to the treatment of intrapulmonary bacterial infections, including treatment of nosocomial pneumonia lung infections with pharmaceutical compositions containing the cephalosporin ceftolozane.
Inventor(s): Chandorkar; Gurudatt A. (Waltham, MA), Huntington; Jennifer A. (Reading, MA), Parsons; Tara (Hanover, MA), Umeh; Obiamiwe C. (Acton, MA)
Assignee: MERCK SHARP & DOHME CORP. (Rahway, NJ)
Application Number:14/512,608
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,724,353: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 9,724,353, exploring its claims, the patent landscape, and the implications of its issuance.

Understanding Patent 9,724,353

To begin, it is essential to identify the patent in question. United States Patent 9,724,353 is a utility patent that was granted on August 8, 2017. Here, we will break down the key components of this patent.

Inventors and Assignees

The inventors and assignees of the patent are critical as they hold the rights and responsibilities associated with the invention. Identifying these parties can help in understanding the commercial and legal context of the patent.

Title and Abstract

The title and abstract provide a brief overview of the invention. This information is vital for initial assessments and can guide further detailed analysis.

Claims Analysis

The claims section of a patent is the most critical part as it defines the scope of the invention.

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are the broadest claims and set the boundaries of the patent.
  • Dependent Claims: These claims refer back to and further limit the independent claims. They often add specific details or narrow down the scope of the invention.

Claim Construction

Claim construction involves interpreting the language of the claims to determine their meaning and scope. This process is crucial in patent litigation and enforcement. For example, the use of clear, concise, and exact terms is mandated by federal statutes to ensure that patent applications meet statutory requirements[1].

Patent Landscape Analysis

A patent landscape analysis provides a broader view of the technological area in which the patent resides.

Identifying Prior Art

Prior art searches are essential to determine the novelty and non-obviousness of the invention. Tools like the USPTO's Patent Public Search and Global Dossier can be used to identify relevant prior art and understand the patent family of related applications[4].

Competitor Analysis

Analyzing the patent portfolios of competitors can reveal strategic insights. For instance, a full patent landscape analysis can show high saturation in a technology area, indicating the need to pivot to newer inventive spaces[3].

Technology Area Saturation

Understanding the level of patent saturation in a particular technology area can help in making long-term decisions about research and development. This involves mapping abandoned and active technologies to identify trends and opportunities[3].

Quality of Patent Applications

The quality of the patent application itself is a significant factor in ensuring that the patent is valid and enforceable.

Clarity and Conciseness

The USPTO emphasizes the importance of clear and concise language in patent applications. Tools such as glossaries of key terms and claim charts can improve the clarity of claims, although the USPTO has decided not to require these tools after stakeholder feedback[1].

Examiner Time and Resources

The time and resources allocated to patent examiners can impact the quality of the examination process. The USPTO has increased the time available for certain art units to ensure thorough examinations[1].

Legal and Regulatory Framework

Understanding the legal and regulatory environment is crucial for navigating patent issues.

Statutory Requirements

Patent applications must meet statutory requirements such as novelty, non-obviousness, and clarity. The USPTO has developed correctness measures and compliance targets to ensure these requirements are met[1].

Potential for Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address patent disputes more efficiently. This could impact how patent holders and challengers approach litigation[5].

Practical Implications

The practical implications of holding or challenging a patent like 9,724,353 are significant.

Enforcement and Litigation

Understanding the claims and scope of the patent is essential for enforcement and litigation. Clear claims can help in defending the patent against challenges and in asserting it against infringers.

Licensing and Commercialization

The clarity and scope of the patent claims also affect licensing and commercialization strategies. A well-defined patent can attract investors and partners, while ambiguous claims can deter them.

Key Takeaways

  • Clear Claims: Clear and concise language in patent claims is crucial for meeting statutory requirements and ensuring the patent's validity.
  • Patent Landscape: Understanding the broader patent landscape helps in strategic decision-making and identifying opportunities and threats.
  • Quality of Applications: The quality of the patent application, including the use of clarity tools, is vital for ensuring thorough examinations and valid patents.
  • Legal Framework: Understanding the legal and regulatory environment, including potential changes like a small claims patent court, is essential for navigating patent issues.

FAQs

What is the importance of clear claims in a patent application?

Clear claims are essential for ensuring that the patent application meets statutory requirements and for facilitating a thorough examination process. They help in defining the scope of the invention clearly, which is crucial for enforcement and litigation[1].

How does patent landscape analysis help in strategic decision-making?

Patent landscape analysis provides a comprehensive view of the technological area, helping businesses and R&D management make long-term decisions about where to focus their resources and how to pivot to newer inventive spaces[3].

What are the statutory requirements for patent applications?

Patent applications must meet requirements such as novelty, non-obviousness, and clarity. The USPTO has developed correctness measures and compliance targets to ensure these requirements are met[1].

Why is the quality of patent applications important?

The quality of patent applications affects the validity and enforceability of the patent. High-quality applications with clear and concise language ensure that the patent can withstand challenges and be effectively enforced[1].

What is the potential impact of a small claims patent court?

A small claims patent court could provide a more efficient and cost-effective way to resolve patent disputes, which could impact how patent holders and challengers approach litigation and enforcement strategies[5].

Sources

  1. GAO Report: Intellectual Property: Patent Office Should Define Quality, Reassess Incentives, and Improve Application Review Process[1].
  2. USPTO Website: U.S. Patent and Trademark Office (USPTO)[2].
  3. AcclaimIP: Patent Landscape Analysis - Uncovering Strategic Insights[3].
  4. USPTO Search Resources: Search for patents - USPTO[4].
  5. ACUS Study: U.S. Patent Small Claims Court[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,724,353

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Cubist Pharms Llc ZERBAXA ceftolozane sulfate; tazobactam sodium POWDER;INTRAVENOUS 206829-001 Dec 19, 2014 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA ⤷  Subscribe
Cubist Pharms Llc ZERBAXA ceftolozane sulfate; tazobactam sodium POWDER;INTRAVENOUS 206829-001 Dec 19, 2014 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF VENTILATOR-ASSOCIATED BACTERIAL PNEUMONIA ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,724,353

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2848012 ⤷  Subscribe
China 103945842 ⤷  Subscribe
Eurasian Patent Organization 028342 ⤷  Subscribe
Eurasian Patent Organization 201490590 ⤷  Subscribe
European Patent Office 2753326 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.